Leonard Sank
Director, Oramed Pharmaceuticals.
Companies
- Oramed PharmaceuticalsBoard member Oct 25, 2007 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Oramed Pharmaceuticals ORMP273,420 shares2$1.1M at $4.18Jun 5, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 5, 2025Granted 6,510 shares of Oramed Pharmaceuticals2
- Jun 5, 2025Granted 30,000 shares of Oramed Pharmaceuticals2
- Jan 4, 2024Granted 9,325 shares of Oramed Pharmaceuticals3
- Jan 4, 2024Granted 30,000 shares of Oramed Pharmaceuticals3
- Apr 17, 2023Granted 30,000 shares of Oramed Pharmaceuticals4
- Aug 8, 2022Shares withheld for tax 9,304 shares at $8.77 of Oramed Pharmaceuticals5
- Aug 8, 2022Exercised options 20,000 shares at $4.08 of Oramed Pharmaceuticals5
- Jul 28, 2022Granted 12,000 shares of Oramed Pharmaceuticals6
- Jan 3, 2022Granted 6,000 shares of Oramed Pharmaceuticals7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAROramed Pharmaceuticals, Board member
- 2
- 3SEC EDGARForm 4 filed Jan 8, 2024
- 4SEC EDGARForm 4 filed Apr 20, 2023
- 5SEC EDGARForm 4 filed Aug 10, 2022
- 6SEC EDGARForm 4 filed Aug 1, 2022
- 7SEC EDGARForm 4 filed Jan 5, 2022